Ukuphatha I-Multiple Sclerosis Nge-Rebif

Okudingeka Ukwazi Ngale Mithi Ye-Interferon

I-Rebif (i-interferon beta 1-a) ingenye yezinhlobo eziningi zokwelashwa eziguqulwa yisifo ekuphatheni i-MS yokubuyisela kabusha (RRMS). Njengamanye ama-interferon therapies, i-Rebif inganciphisa inani lokubuyiselwa kabusha komuntu onama-RRMS anesilinganiso sesithathu. Lokhu kuhle, kodwa kukhona izinto ezibalulekile zokwazi mayelana neRebif, kufaka phakathi izinzuzo zayo ngaphezu kweminye imithi kanye nokungahleleki nemiphumela emibi engase ibe khona.

Izinzuzo kanye Nokwamukela Ukuthatha Rebif

Izinaliti zeRebif zincane kakhulu futhi zijova zingaphansi kwamagama-ngamanye amazwi, inaliti kufanele ingene ngaphansi kwesikhumba, okungaba buhlungu kakhulu kunezijova ezijulile. Ngakolunye uhlangothi, u-Rebif une-pH ephansi, ngakho-ke yinto enamandla futhi engenza kube buhlungu kancane uma ifakwe. Futhi, i-Rebif idinga ukuthathwa kathathu ngesonto, kanti amanye ama-interferon adinga ukujova kanye kanye ngesonto.

Uma u-Rebif, kuzodingeka ube nomsebenzi wegazi njalo ukuze uhlole izibalo ezingaphansi kwegazi kanye nezinkinga zesibindi futhi kuzodingeka uqashwe ngokucophelela ngokucindezeleka. Kuhle ukuphawula ukuthi ukucwaninga ukuphakamisa ukucindezeleka kuyingozi kakhulu ngeRebif kunemithi efanayo.

Ukwengeza, i-Rebif ilula ukuhamba nayo: Iza kuma-syringes asetshenzisiwe (ayikho ukuxuba) futhi ayigcinwa ebanda efrijini.

Imiphumela emibi engenzeka

Imiphumela emibi yeRebif ifana neyenye imithi yokwelashwa e-interferon.

Kungase kungabi ephephile kumuntu onenkinga yokuthumba ukuthatha uRebf, futhi abesifazane abakhulelwe kufanele bangasebenzisi lesi sidakamizwa: Izifundo zezilwane ziye zathola ukuthi zingalimaza izingane. Uma usuRebif futhi ufuna ukukhulelwa, udokotela wakho angase ayeke ukuthatha Rebif izinyanga ezintathu kuya kwezinyanga ngaphambi kokuba uqale ukuzama ukukhulelwa.

Imithombo:

U-Manfredonia F, uPasquali L, uDardano A, u-Iudice A, u-Murri L, uMonzani F. "Ukubuyekezwa kobufakazi be-Clinical For Interferonβ 1a (Rebif) ku-Treatment of Multiple Sclerosis." I- NeuropsychiatrDisTreat . 2008; 4 (2): 321-36.

I-National MS Society. " Izifo-Ukuguqula Imithi Ye-MS ." 2016.

Iqembu le-PRISMS Yokufunda. "I-PRISMS-4: Ukusebenza Kwesikhathi Eside E-Interferon-Beta-1a ekubuyiseleni i-MS." I-Neurology 2001; 56: 1628-1636.

I-Panitch H, i-Goodin DS, uFrancis G, et al. "Okungahleliwe, Ucwaningo Lokuqhathaniswa Kwe-Interferon Beta-1a Imigomo Yokwelapha ku-MS: I-EVIDENCE Trial." I-Neurology 2002; 59: 1496-1506.

Smith B et al. Ukubuyekezwa kwezidakamizwa: Izifo-Ukuguqula izidakamizwa ze-Multiple Sclerosis: Ukubuyekeza kokugcina 1 Umbiko. "Portland (OR): University of Oregon Health and Science; 2010 Aug.